At the news
? NEUTRALIMPACT 3/10 CLUSTER filed Mar 5, 2026 at 19:00 ET
United Therapeutics CEO Martine Rothblatt sold 1,156 shares in two open-market transactions totaling $616,635 over the past week, while also exercising options for 19,000 shares at a mix of $0 and $146.03 strike prices. The sales represent a small fraction of market cap and are likely part of pre-arranged trading plans or tax-related activity following option exercises.
- CEO Martine Rothblatt sold 1,156 shares in open-market transactions for $616,635 over two days.
- Concurrent with the sales, Rothblatt exercised 19,000 derivative securities, including 9,500 shares at $0 (likely RSU vesting) and 9,500 at $146.03 (in-the-money options).
- Total open-market sale value: $616,635, approximately 0.0026% of $23.5B market cap.
- All transactions occurred within a 5-day window, suggesting coordinated activity likely tied to option exercise and tax obligations.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access